Improved efficacy in gene therapy of hemophilia A using an AAV6 pseudo-typed FVIII vector

被引：0
作者：
Jiang, HY [1 ]
Patarroyo-White, S [1 ]
Nagy, D [1 ]
Vargas, J [1 ]
Scallan, C [1 ]
Liu, TY [1 ]
Powell, S [1 ]
Wright, F [1 ]
Couto, L [1 ]
机构：
[1] Avigen Inc, Alameda, CA USA
来源：
MOLECULAR THERAPY | 2003年 / 7卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
471
引用
收藏
页码：S184 / S184
页数：1
相关论文
共 50 条
  • [21] Post- transcriptional fine-tuning of AAV vector gene expression for hemophilia A gene therapy
    Domenger, C.
    Kachel, B.
    Niopek, D.
    Grimm, D.
    HUMAN GENE THERAPY, 2018, 29 (12) : A156 - A156
  • [22] Post-Transcriptional Fine-Tuning of AAV Vector Gene Expression for Hemophilia A Gene Therapy
    Domenger, Claire
    Kachel, Benjamin
    Niopek, Dominik
    Grimm, Dirk
    MOLECULAR THERAPY, 2018, 26 (05) : 435 - 436
  • [23] Development of an AAV DNA-based synthetic vector for the potential gene therapy of hemophilia in children
    Shoti, Jakob
    Qing, Keyun
    Srivastava, Arun
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [24] Molecular evaluation and vector integration analysis of HCC complicating AAV gene therapy for hemophilia B
    Schmidt, Manfred
    Foster, Graham R.
    Coppens, Michiel
    Thomsen, Hauke
    Dolmetsch, Ricardo
    Heijink, Liesbeth
    Monahan, Paul E.
    Pipe, Steven W.
    BLOOD ADVANCES, 2023, 7 (17) : 4966 - 4969
  • [25] NGGT003, an Advanced Gene Therapy Vector Carrying a New FVIII Variant for Treating Hemophilia A
    Cao, Qing
    Wang, Qingzhou
    Guo, Yufeng
    Wen, Shengmei
    Liu, Yiting
    Qu, Guang
    Jiang, Lixin
    MOLECULAR THERAPY, 2024, 32 (04) : 489 - 490
  • [26] Vector Analysis of Multicentric Lymphoma in a Severe Hemophilia. Dog after AAV Gene Therapy
    Van Gorder, Lucas
    Doshi, Bhavya S.
    Willis, Elinor
    Lanza, Matthew
    Arruda, Valder R.
    Callan, Mary Beth
    Samelson-Jones, Ben J.
    BLOOD, 2022, 140 : 4919 - 4920
  • [27] Development of a Clinical Candidate AAV3 Vector for the Potential Gene Therapy of Hemophilia B
    Brown, Harrison
    Doering, Christopher B.
    Herzog, Roland W.
    Ling, Chen
    Markusic, David M.
    Spencer, H. Trent
    Srivastava, Alok
    Srivastava, Arun
    MOLECULAR THERAPY, 2020, 28 (04) : 261 - 261
  • [28] Case Study on Insect Cell-Produced AAV6 Gene Therapy Vector in a Rhabdovirus-Free Sf9 Cell Line
    Mulvania, Thera
    Hayes, Brooks C.
    Walker, Scott
    Rodgers, Buel D.
    Rininger, Joseph
    MOLECULAR THERAPY, 2024, 32 (04) : 722 - 722
  • [29] Inducible caspase 9-mediated suicide gene therapy using AAV6 vectors in a murine model of breast cancer
    Pathak, Subhajit
    Singh, Vijayata
    Kumar, Narendra
    Jayandharan, Giridhara R.
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2023, 31
  • [30] Efficacy and Safety in 15 Hemophilia B Patients Treated with the AAV Gene Therapy Vector Fidanacogene Elaparvovec and Followed for at Least 1 Year
    George, Lindsey A.
    Sullivan, Spencer K.
    Rasko, John E. J.
    Giermasz, Adam
    Samelson-Jones, Benjamin J.
    Ducore, Jonathan M.
    Teitel, Jerome M.
    McGuinn, Catherine E.
    Runowski, Alexa R.
    Wright, Fraser
    Anguela, Xavier M.
    High, Katherine A.
    Rybin, Denis
    Murphy, John E.
    Rupon, Jeremy
    BLOOD, 2019, 134
12345